OBJECTIVES: To determine whether the introduction of heated humidified high-flow nasal
cannulae (HFNC) therapy was associated with decreased rates of intubation for infants< 24 …

Background Viral bronchiolitis is the leading cause of hospitalization in children during the
first 12 months of life. There is evidence to support the use of noninvasive ventilation in …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

Abstract High Flow Nasal Cannula therapy (HFNC) is a form of respiratory support for
bronchiolitis. Recent evidence confirms HFNC reduces the risk of treatment escalation by …

Objectives To review the effects and safety of high-flow nasal cannula (HFNC) for
bronchiolitis. Methods Six electronic databases including PubMed, EMBASE, Cochrane …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

High-flow nasal cannula (HFNC) is a relatively recent therapy that has been used to treat
respiratory failure. Until now, the criterion for failure requiring escalation to other forms of …

BACKGROUND: High-flow nasal cannula (HFNC) is increasingly utilized in pediatrics,
delivering humidified air and oxygen for respiratory conditions causing hypoxia and distress …

Inpatient bronchiolitis outcomes in North America have changed substantially during the
past 4 decades. Annual deaths associated with bronchiolitis in the United States were once …

Background High flow nasal cannula (HFNC) is a respiratory device increasingly used to
treat asthma. Recent mechanistic studies have shown that nebulized medications may have …